Literature DB >> 25152235

ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15(S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation.

Sivareddy Kotla1, Nikhlesh K Singh1, James G Traylor2, A Wayne Orr2, Gadiparthi N Rao3.   

Abstract

15(S)-Hydroxyeicosatetraenoic acid (15(S)-HETE), the major 15-lipoxygenase 1/2 (15-LO1/2) metabolite of arachidonic acid (AA), induces CD36 expression through xanthine oxidase and NADPH oxidase-dependent ROS production and Syk and Pyk2-dependent STAT1 activation. In line with these observations, 15(S)-HETE also induced foam cell formation involving ROS, Syk, Pyk2, and STAT1-mediated CD36 expression. In addition, peritoneal macrophages from Western diet-fed ApoE(-/-) mice exhibited elevated levels of xanthine oxidase and NADPH oxidase activities, ROS production, Syk, Pyk2, and STAT1 phosphorylation, and CD36 expression compared to those from ApoE(-/-):12/15-LO(-/-) mice and these events correlated with increased lipid deposits, macrophage content, and lesion progression in the aortic roots. Human atherosclerotic arteries also showed increased 15-LO1 expression, STAT1 phosphorylation, and CD36 levels as compared to normal arteries. Together, these findings suggest that 12/15-LO metabolites of AA, particularly 12/15(S)-HETE, might play a crucial role in atherogenesis by enhancing foam cell formation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD36; Foam cell; ROS; STAT1; Syk

Mesh:

Substances:

Year:  2014        PMID: 25152235      PMCID: PMC4253592          DOI: 10.1016/j.freeradbiomed.2014.08.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  53 in total

Review 1.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

2.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.

Authors:  E A Podrez; M Febbraio; N Sheibani; D Schmitt; R L Silverstein; D P Hajjar; P A Cohen; W A Frazier; H F Hoff; S L Hazen
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.

Authors:  Asako Katsume; Mitsuhiko Okigaki; Akihiro Matsui; Jishan Che; Yasushi Adachi; Eigo Kishita; Shinichiro Yamaguchi; Koji Ikeda; Tomomi Ueyama; Satoaki Matoba; Hiroyuki Yamada; Hiroaki Matsubara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-03       Impact factor: 8.311

4.  Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice.

Authors:  D Harats; A Shaish; J George; M Mulkins; H Kurihara; H Levkovitz; E Sigal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

Review 5.  Progress and challenges in translating the biology of atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

6.  Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.

Authors:  T Cyrus; D Praticò; L Zhao; J L Witztum; D J Rader; J Rokach; G A FitzGerald; C D Funk
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

7.  Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice.

Authors:  Melissa E Hatley; Suseela Srinivasan; Kelly B Reilly; David T Bolick; Catherine C Hedrick
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

8.  Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice.

Authors:  Margarete Mehrabian; Hooman Allayee; Jack Wong; Weibin Shi; Xu-Ping Wang; Zory Shaposhnik; Colin D Funk; Aldons J Lusis; Weibin Shih
Journal:  Circ Res       Date:  2002-07-26       Impact factor: 17.367

9.  A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Maria Febbraio; David P Hajjar; Roy L Silverstein; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents.

Authors:  Noriyuki Yamamoto; Keisuke Takeshita; Michitaka Shichijo; Toshio Kokubo; Masako Sato; Kosuke Nakashima; Mina Ishimori; Hiroichi Nagai; Ying-Fu Li; Takeshi Yura; Kevin B Bacon
Journal:  J Pharmacol Exp Ther       Date:  2003-05-23       Impact factor: 4.030

View more
  13 in total

1.  Membrane-dependent Activities of Human 15-LOX-2 and Its Murine Counterpart: IMPLICATIONS FOR MURINE MODELS OF ATHEROSCLEROSIS.

Authors:  Gunes Bender; Erin E Schexnaydre; Robert C Murphy; Charis Uhlson; Marcia E Newcomer
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

2.  Linking Metabolic Dysfunction to Atherosclerosis Via Activation of Macrophage CD36 Gene Transcription by Retinol Binding Protein-4.

Authors:  Roy L Silverstein
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

3.  Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.

Authors:  Xiaoxiao Yang; Hui Yao; Yuanli Chen; Lei Sun; Yan Li; Xingzhe Ma; Shengzhong Duan; Xiaoju Li; Rong Xiang; Jihong Han; Yajun Duan
Journal:  J Biol Chem       Date:  2015-07-17       Impact factor: 5.157

Review 4.  Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation.

Authors:  Manuel U Ramirez; Elizabeth R Stirling; Nancy J Emenaker; David D Roberts; David R Soto-Pantoja
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

Review 5.  12/15 Lipoxygenase as a Therapeutic Target in Brain Disorders.

Authors:  Hulya Karatas; Canan Cakir-Aktas
Journal:  Noro Psikiyatr Ars       Date:  2019-09-05       Impact factor: 1.339

6.  ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation.

Authors:  Sivareddy Kotla; Nikhlesh K Singh; Gadiparthi N Rao
Journal:  Redox Biol       Date:  2016-12-07       Impact factor: 11.799

7.  15-oxoeicosatetraenoic acid mediates monocyte adhesion to endothelial cell.

Authors:  Guohua Ma; Bing Pan; Sufen Ren; Caixia Guo; Yansong Guo; Lixin Wei; Lemin Zheng; Buxing Chen
Journal:  Lipids Health Dis       Date:  2017-07-12       Impact factor: 3.876

8.  The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.

Authors:  Yusuke Kamihara; Kohichi Takada; Tsutomu Sato; Yutaka Kawano; Kazuyuki Murase; Yohei Arihara; Shohei Kikuchi; Naotaka Hayasaka; Makoto Usami; Satoshi Iyama; Koji Miyanishi; Yasushi Sato; Masayoshi Kobune; Junji Kato
Journal:  Oncotarget       Date:  2016-09-27

9.  Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-γ in CD36 Protein Expression and Foam Cell Formation.

Authors:  Sivareddy Kotla; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2015-10-25       Impact factor: 5.486

10.  Impaired type I interferon regulation in the blood transcriptome of recurrent asthma exacerbations.

Authors:  Jose L Gomez; Maria P Diaz; Gustavo Nino; Clemente J Britto
Journal:  BMC Med Genomics       Date:  2018-02-27       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.